Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03PDZ
|
||||
Former ID |
DPR000035
|
||||
Drug Name |
D1 agonist D2 antagonist
|
||||
Indication | Schizophrenia [ICD9: 295; ICD10:F20] | Preclinical | [536463] | ||
Company |
Eli Lilly
|
||||
Target and Pathway | |||||
Target(s) | D(2) dopamine receptor | Target Info | Antagonist | [536463] | |
Dopamine D1 receptor | Target Info | Agonist | [536463] | ||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Dopamine receptor mediated signaling pathway | |||||
Nicotine pharmacodynamics pathwayP05912:Dopamine receptor mediated signaling pathway | |||||
PathWhiz Pathway | Dopamine Activation of Neurological Reward System | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.